Broncus Closes Series C Financing
Funds Will Support Further Development of Interventional Technologies for Navigation and Treatment of Diseases Across the Lung
Broncus Holding Company ("Broncus"), a global leader in...
Hua Medicine Announces the Drug Manufacturing Permit Granted for Dorzagliatin
Hua Medicine (the "Company", Stock Code: 2552.HK) announces that, after review and on-site verification under the Marketing Authorization Holder ("MAH") system, the Company has...
Olympus Launches ENDO-AID, an AI-Powered Platform for Its Endoscopy System
Olympus Corporation today announced the launch of ENDO-AID(1), a cutting-edge platform powered by artificial intelligence (AI) that includes the endoscopy application ENDO-AID CADe (computer-aided...
Woori BMO Group Reports on Clover Health as They Go Public in $3.7 Billion...
Woori BMO Group has today commented on Clover Health, the insurance start-up backed by Alphabet Inc. and Sequoia, as it agrees to go public...
Tianda Pharmaceuticals acquired and established a long-term relationship of Cooperation with Yeung & Young...
Tianda Pharmaceuticals Limited ("Tianda Pharmaceuticals", together with its subsidiaries as the "Group", Stock Code: 455.HK) is pleased to announce that its wholly-owned subsidiary, TDMall...
Impact BioMedical to Begin Efficacy Testing of Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary...
Document Security Systems, Inc. ("DSS" or the "Company") (NYSE American: DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct...
Holista Signs Agreement with Costanzo’s to Launch World’s Lowest Glycaemic Index (GI) Clean Label...
3-y deal for GI Lite™, low GI white bread for US, Canada & Mexico markets
165 tons for US$1.9m 1st year, 220 tons...
Aptorum Group Launches Infectious Disease Liquid Biopsy Subsidiary Start-up and Exclusively In-licensed from Singapore...
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ) ("Aptorum Group" or "Aptorum"), a biopharmaceutical company focused on novel technologies including the targeting of...
Insumate(R)–Patented Peptide Sequence mcIRBP-19: a Boon for Diabetics Says Greenyn Biotechnology
Taiwan's biotech is gradually emerging. During the COVID-19 epidemic, we had a chance to see the advanced medical equipment and the effective preventive measures...
Agilex Biolabs Develops World’s Most Accurate Cannabinoid Assay
Award-winning Agilex Biolabs, the Asia-Pacific region's leading bioanalytical laboratory for clinical trials, based in Australia, has developed the world's most accurate cannabinoid assay.
The announcement...
Avance Clinical Announces Expanded eClinical Solutions for Biotech Clinical Trials at BioPharm America
The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner, Avance Clinical has expanded its eClinical solutions...
Aptorum Group to Hold Investor Webinar and Present at The Wall Street Investor Forum...
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a biopharmaceutical company focused on novel therapeutics including the development of next-generation...
Huge chance to innovate as online medical services take root, Platform makes name for...
Digital healthcare will play a major role in changing people's lives and health as the development of internet-based medical care in China grows, said...
Avance Clinical Client Immunic, Inc. Announced Dosing of First Healthy Volunteer in Phase 1...
The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical is pleased to share the...
Regent Pacific enters longevity medicine business driven by leading AI technology through acquisition of...
Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; Hong Kong stock code: 00575), a specialist healthcare,...
Aptorum Group Announces Further Positive Data on ALS-4 against MRSA Wound Infection and MRSA...
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group"), a biopharmaceutical company focused on novel therapeutics including the development of next-generation approach therapeutics...
Aptorum Group Announces Further Positive Data on SACT-1 Against Neuroblastoma and Other Potential Tumor...
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics including orphan diseases and...
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended...
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group"or the "Company"), a biopharmaceutical company focuses on the development of novel therapeutics to address...
Junshi Biosciences Announces Financial Results for Six Months Ended June 30, 2020 and Provides...
-- Supplemental NDAs for Toripalimab filed
-- Expanding into infectious disease and collaborating with IMCAS and Lilly for COVID-19 neutralizing antibodies
-- Dual Listing on the...
Lee’s Pharm Announces 2020 Interim Results
Profit Attributable to the Owners of the Company Increased by 153.3%
Actively Develop New Products
Reform and Replenish the Sales Organisation
Lee's Pharmaceutical Holdings Limited ("Lee's Pharm"...
